References

  1. Leishman WB. On the possibility of occurrence of trypanosomiasis in India. Indian J Med Res. 2006 Mar;123(3):1252-4. PubMed | Google Scholar

  2. Desjeux Phillippe. Human leishmaniases: epidemiology and public health aspects. World Health Stat Q. 1992; 45: 267-275. PubMed | Google Scholar

  3. Murray Henry, Berman Jonathan, Davies Clive, Saravia Nancy. Advances in leishmaniasis. Lancet. 2005; 366 (9496): 1561-1577. PubMed | Google Scholar

  4. Zijlstra Edward, Musa Ahmed, Khalil Eltahir , El Hassan Ibrahim Mohmaed, El Hassan Ahmed Mohamed. Post-kala-azar dermal leishmaniasis. Lancet Inf Dis. 2003; 3(2): 87-98. PubMed | Google Scholar

  5. World Health Organization. Magnitude of the problem. Available : http://www.who.int/leishmaniasis/burden/magnitude/burden_magnitude/en/index.html. Accessed on 7 January 2012.

  6. Elnaiem Dia-Eldin. Ecology and control of the sand fly vectors of Leishmania donovani in East Africa, with special emphasis on Phlebotomus orientalis. J Vector Ecology. 2011; 36 (supplement 1): S23-S31. PubMed | Google Scholar

  7. Sacks David and Kamhawi Shaden. Molecular aspects of parasite vector and vector host interactions in leishmaniasis. Annual Rev Microbiol. 2001; 55: 453-483. PubMed | Google Scholar

  8. Bray Robert. Leishmania. Annual Reviews. 1974; 28: 189-217. PubMed | Google Scholar

  9. Seridi Nabila, Amro Ahmad, Kuhls Katrin, Belkaid Miloud, Zidane Charef, et al. Genetic polymorphism of Algerian Leishmania infantum strains revealed by multilocus microsatellite analysis. Microbes Infect. 2008; 10 (12-13): 1309-1315. PubMed | Google Scholar

  10. Chargui Najila, Amro Ahmad, Haouas Najoua, Schonian Gabriele, Babba Hamouda, et al. Population structure of Tunisian Leishmania infantum and evidence for the existence of hybrids and gene flow between genetically different populations. Int J Parasitol. 2009; 39 (7): 801-811. PubMed | Google Scholar

  11. Reithinger Richard, Brooker Simon, Kolaczinski Jan. Visceral leishmaniasis in eastern Africa-current status. Trans Roy SocTrop Med Hyg. 2007; 101 (12): 1169-1170. PubMed | Google Scholar

  12. Karamoja. Available at http://en.wikipedia.org/wiki/Karamoja. Accessed in January 2012.

  13. McKinnon John. Kala azar in the Upper Rift Valley of Kenya Part 1: Background and discovery of the disease. J Trop Med Hyg. 1962; 65:51-63. PubMed | Google Scholar

  14. Hutt Michael. Some aspects of liver disease in Ugandan Africans. Trans Roy Soc Trop Med Hyg. 1971; 65 (3): 273-281. PubMed | Google Scholar

  15. Sondorp Egbert. Kala azar in Pokot County, Moroto District, Uganda: Assessment of epidemiological and clinical situation. Consultancy commissioned by MSF, Switzerland. 1999; 1-38.

  16. Marlet Michael, Sang David, Ritmeijer Koert, Muga Richard, Onsongo Joyce, Davidson Robert. Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya and south-eastern Ethiopia in 2000-01. Trans Roy Soc Trop Med Hyg. 2003; 97 (5):515-518. PubMed | Google Scholar

  17. Mutero Clifford, Mutinga Mutuku, Ngindu Augustine, Kenya PR, Amino Fred. Visceral leishmaniasis and malaria prevalence in West Pokot district, Kenya. East Afr Med J. 1992; 69 (1): 3-8. PubMed | Google Scholar

  18. Jamjoon Manal, Ashford Richard, Bates Paul et al. Leishmania donovani is the only cause of visceral leishmaniasis in East Africa: previous descriptions of L infantum and L archibaldi from this region are a consequence of convergent evolution in the isozyme data. Parasitology. 2004; 129 (4): 399-409. Google Scholar

  19. Chappuis Francois,Cavailler Philippe. Perception of kala azar among Pokot communities in Amudat, Eastern Uganda. Epicentre MSF study report 2002. version 4. 1-40.

  20. Waykoff Dale , Barnley George, Winn Max . Studies of kala-azar in Uganda-Entomological observations. East Afr Med J. 1969; 46 (4):204-207. PubMed | Google Scholar

  21. Manson-Bahr Patrick, Southgate Brian. Recent research on kala-azar in East Africa. J Trop Med Hyg. 1964 Apr;67:79-84. PubMed | Google Scholar

  22. Pagliano Pasquale, Carannante Novella, Rossi Marco, Gramiccia Marina, Gradoni Luigi, et al. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother. 2005; 55 (2):229-233. PubMed | Google Scholar

  23. Drugs for Neglected Diseases initiative. Available from http://www.DNDi.org
    24. . Accessed on 7 January 2012.
  24. MSF (Medecins sans Frontieres). MSF kala-azar project in Pokot area: summary report of medical activities period: 2000-2004, 2005.

  25. Ngoka Johnson, Mutinga Mutuku. The dog as a reservoir of visceral leishmaniasis in Kenya. Trans Roy Soc Trop Med Hyg. 1977;71 (5): 447-448. PubMed | Google Scholar

  26. Mutinga Mutuku, Ngoka Johnson. Culture, isolation and description of cutaneous leishmaniasis in Kenya: A preliminary report. East Afr Med Res Council Sci Conf. 1970; 4: 72-74. PubMed | Google Scholar

  27. Sang David, Okelo GBA, Chance Michael. Cutaneous leishmaniasis due to Leishmania aethiopica, on Mount Elgon, Kenya. Ann Trop Med Parasitol. 1993; 87 (4): 349-357. PubMed | Google Scholar

  28. Bryceson Anthony. Diffuse cutaneous leishmaniasis in Ethiopia: Historical features of the disease. Trans Roy Soc Trop Med Hyg. 1969; 63 (5): 708-737. PubMed | Google Scholar

  29. Abdalla Rashid, Ali Mahdavi, Wasfi Al, El Hassan Ahmed Mohamed. Cutaneous leishmaniasis in the Sudan. Trans Roy Soc Trop Med Hyg. 1973; 67 (4): 549-559. PubMed | Google Scholar

  30. World Health Organization (WHO). Leishmaniases Sixth Prog. Rep TRD/PR-6/83 7- LEISH Chapter 7. 1983; 193-205.

  31. Bucheton Bruno, Kher Musa, El-Safi Sayda, Hammad Awad, Mergani Adil, Mary Charles, Abel Laurent, Dessein Alain. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes and Infection. 2002; 4 (14):1449-57. PubMed | Google Scholar

  32. Mohamed Hiba Salah, Ibrahim Muntaser Eltayab, Miller Elior Nancy, et al. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet. 2004; 12 (1):66-74. PubMed | Google Scholar

  33. Kolaczinski Jan, Reithinger Richard, Worku Dagemlidet, Ocheng Andrew, et al. Risk factors for visceral leishmaniasis in East Africa: a case control study in Pokot territory of Kenya and Uganda. Int J Epidemiol. 2008; 37 (2): 344-352. PubMed | Google Scholar

  34. Mueller Yolanda, Mbulamberi Dawson, Odermatt Peter, Hoffmann Axel, et al. Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda.Trop Med Internat Health. 2009; 14 (8): 910-917. PubMed | Google Scholar

  35. Thukur Chandreshwar. Socio-economics of visceral leishmaniasis in Bihar (India). Trans Roy SocTrop Med and Hyg. 2000; 94 (2): 156-157. PubMed | Google Scholar

  36. Herwaldt Barbara. Leishmaniasis. Lancet.1999;354 (9187): 1191-1199. PubMed | Google Scholar

  37. Arias Jorge, Monteiro Pedro, Zicker Fabio. The re-emergence of visceral leishmaniasis in Brazil. Emer Infect Dis. 1996;2 (2):145-146. PubMed | Google Scholar

  38. Southgate Brian. The structure of foci of visceral leishmaniasis in north-eastern Kenya. Collques Intern Centre Nat Recherche Scientif. 1977; 239: 241-247. PubMed | Google Scholar

  39. Chappuis Francois, Mueller Yolanda, Nguimfack Alexandre, Rwakimari John Bosco, et al. Diagnostic accuracy of two rK39 antigen-based dipsticks and the formal gel test for rapid diagnosis of visceral leishmaniasis in north-eastern Uganda. J Clin Microbiol. 2005; 43 (12): 5973-5977. PubMed | Google Scholar

  40. Harith Abdallah, Kolk Arend Hero, Leewenburg Johannis, Muigai Richard, et al. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol. 1988 ; 26 (7):1321-1325. PubMed | Google Scholar

  41. Mueller Yolanda, Nguimfack Alexandre, Cavailler Philippe, Couffignal Sophie, et al. Safety and effectiveness of Amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda. Ann Trop Med Parasitol. 2008; 102 (1): 11-19. PubMed | Google Scholar

  42. Ahmed Musa, Eltahir Khalil, Asrat Hailu, Joseph Olobo, Balasegaram Manica et al. Paromomycin sulphate alone or in combination with sodium stibogluconate for visceral leishmaniasis treatment in East Africa: A multi-center, open, randomized controlled trial. PLoS (Negl Trop Dis). 2012;6(6):e1674. PubMed | Google Scholar

  43. WHO Technical report series 949. Control of Leishmaniasis. Report of a meeting of the WHO expert committeee on the control of Leishmaniases, Geneva. 22-26 March 2010. Google Scholar

  44. Chappuis Francois, Sundar Shyam, Hailu Asrat, Ghalib Hashim, Rijal Suman, et al. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007; 5 (11): 873-882. Google Scholar

  45. Bern Caryn, Courtenay Orin, Alvar Jorge. Of cattle, sand flies and men: A systematic review of risk factor analyses for south Asian visceral leishmaniasis and implications for elimination. PLoS Neg Trop Dis. 2010; 4 (2): e599.doi:10.1371. PubMed | Google Scholar

  46. Alvar Jorge, Yactayo Sergio, and Bern Caryn. Leishmaniasis and poverty. Trends Parasitol. 2006;22 (12):552-557. PubMed | Google Scholar

  47. Rijal Suman, Koirala Shekhar, Van der Stuyft Patrick, Boelaert Marleen. The economic burden of visceral leishmaniasis for households in Nepal. Trans Roy Soc Trop Med Hyg. 2006; 100 (9): 838-841. PubMed | Google Scholar

  48. Yamey Gavin, and Torreele Els. The world's most neglected diseases. BMJ. 2002 Jul 27;325(7357):176-7. PubMed | Google Scholar

  49. Malaria Consortium (2010) Leishmaniasis control in eastern Africa: Past present efforts and future needs. Situation and gap analysis. November 2010; 86.